Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines

Blood. 1993 Dec 15;82(12):3760-9.

Abstract

With erythroid differentiation, committed progenitor cells acquire the ability to respond to erythropoietin (Epo). Epo interacts with target cells through the Epo receptor (Epo-R), whose expression is tightly regulated in a lineage-specific fashion. Epo-R expression is presumed to be progressively activated or repressed as cells progress along the erythroid or the myeloid pathway, respectively. Little is known of the mechanisms that underlie the erythroid-specific expression of the Epo-R gene. GATA-1, the major known transcription factor involved in Epo-R gene regulation, is not erythroid-specific. We have studied the regulation of the expression of the Epo-R gene in two related human Epo-responsive cell lines, UT-7 and UT-7 Epo. These lines express Epo-R at high levels because of amplification of the endogenous gene, which is apparently not rearranged. Treatment for 6 to 24 hours with the tumor promoter, phorbol myristate acetate (PMA), or 24 hours of growth factor starvation (Epo or granulocyte/macrophage colony-stimulating factor [GM-CSF]) decreased or increased the levels of Epo-R mRNA, respectively. In the case of growth factor starvation, the increase (approximately equal to threefold) in the level of Epo-R mRNA correlated directly with an increase in the rate of Epo-R gene transcription as measured by run-off assay. Both increases were observed as early as 3 hours after the growth factor was withdrawn and were reversible; levels of mRNA and transcription rates returned to baseline 3 hours after the cells were reexposed to growth factors. The changes in Epo-R expression after growth factor starvation were coordinated with changes in the level of expression of GATA-1 that were detected both at the mRNA and at the gene transcription level under these conditions (suggesting that GATA-1 was responsible for this upregulation). During PMA treatment, after a transient increase in Epo-R mRNA at 1 hour, a progressive decline in the level of Epo-R mRNA was observed; the level of Epo-R mRNA decreased by 50%, and fell below the level of detection by 6 and 24 hours, respectively. This decrement was explained in part by a fourfold reduction in the rate of gene transcription as well as a reduction (measured as levels of Epo-R mRNA in the presence of actinomycin D) in mRNA stability. The changes in transcription rate occurred in the absence of changes in the level of GATA-1 binding activity.(ABSTRACT TRUNCATED AT 400 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Northern
  • Cell Division / drug effects
  • Cell Line
  • DNA-Binding Proteins / biosynthesis*
  • Erythroid-Specific DNA-Binding Factors
  • Erythropoietin / pharmacology*
  • GATA1 Transcription Factor
  • Gene Expression Regulation* / drug effects
  • Glyceraldehyde-3-Phosphate Dehydrogenases / biosynthesis
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Humans
  • Kinetics
  • Oncogenes / drug effects
  • RNA Processing, Post-Transcriptional*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / isolation & purification
  • RNA, Messenger / metabolism
  • Receptors, Erythropoietin / biosynthesis*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Time Factors
  • Transcription Factors / biosynthesis*
  • Transcription, Genetic*
  • Zinc Fingers

Substances

  • DNA-Binding Proteins
  • Erythroid-Specific DNA-Binding Factors
  • GATA1 Transcription Factor
  • GATA1 protein, human
  • RNA, Messenger
  • Receptors, Erythropoietin
  • Transcription Factors
  • Erythropoietin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • Tetradecanoylphorbol Acetate